RESOURCES | PRESENTATIONS, PUBLICATIONS, AND POSTERS | Innovative combinatorial approach to characterize the immune landscape and analyze the tumor response after anti-PD1 blockade in a 3D Ex-Vivo tumoroid system of non-small cell lung cancer
     

    Innovative combinatorial approach to characterize the immune landscape and analyze the tumor response after anti-PD1 blockade in a 3D Ex-Vivo tumoroid system of non-small cell lung cancer

    Nov 11, 2018

    Melba Marie Page Ph.D., Melanie Mediavilla-Varela Ph.D., Jenny Kreahling, Ph.D., Soner Altiok, M.D., Ph.D. Nilogen Oncosystems. The Society for Immunotherapy of Cancer (SITC). 11/07/2018 to 11/11/18.  Washington, DC, USA.

    DOWNLOAD poster

    OTHER PUBLICATIONS

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue

    Jared Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Pastoor...

    Jun 22, 2020

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME

    Jared C. Ehrhart, Ph.D., Mibel Pabón, Ph.D., Tina Past...

    Jun 22, 2020

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Leveraging Artificial Intelligence to Advance Immuno-oncology Drug Development Using Functional Ex Vivo 3D-tumor Organoid Platforms of Fresh Patient Samples

    Vijayendra Agrawal Ph.D. , Mibel Pabon, Ph.D. , Tina Pa...

    Nov 13, 2019

    SHOW MORE